Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Alnylam Pharmace. | 46 | 0 | 8 | 0 | 218,30 € | 250,79 € | 14,88 % |
| Neurocrine Bioscience | 34 | 0 | 3 | 0 | 134,55 € | 144,01 € | 7,03 % |
| Acadia Pharmaceuticals | 29 | 1 | 3 | 0 | 16,31 € | 31,28 € | 91,79 % |
| United Therapeutics | 23 | 0 | 2 | 0 | 306,10 € | 290,24 € | -5,18 % |
| Ultragenyx Pharmaceutical Inc. | 23 | 1 | 1 | 0 | 41,80 € | 86,28 € | 106,41 % |
| Halozyme Therapeutics Inc. | 20 | 0 | 1 | 0 | 50,90 € | 53,50 € | 5,10 % |
| Ionis Pharmaceuticals Inc. | 25 | 5 | 5 | 0 | 46,82 € | 56,86 € | 21,45 % |
| Iovance Biotherapeutics Inc. | 22 | 2 | 1 | 0 | 8,42 € | 26,25 € | 211,71 % |
| Exelixis Inc. | 20 | 0 | 2 | 0 | 20,70 € | 26,01 € | 25,63 % |
| Arrowhead Pharmaceuticals Inc. | 21 | 2 | 5 | 0 | 26,68 € | 54,98 € | 106,08 % |
| Medpace Holdings Inc | 17 | 0 | 6 | 0 | 352,70 € | 418,12 € | 18,55 % |
| Repligen Corp. | 13 | 0 | 1 | 0 | 121,20 € | 182,96 € | 50,96 % |
| Xencor Inc. | 14 | 1 | 0 | 0 | 18,70 € | 31,70 € | 69,50 % |
| Charles River Labs Intl | 12 | 0 | 1 | 0 | 205,40 € | 248,57 € | 21,02 % |
| Amicus Therapeutics Inc. | 7 | 0 | 0 | 0 | 9,35 € | 17,64 € | 88,64 % |
| Agios Pharmaceuticals Inc. | 8 | 1 | 0 | 1 | 43,80 € | 48,75 € | 11,30 % |
| PTC Therapeutics Inc. | 14 | 9 | 1 | 0 | 30,80 € | 41,46 € | 34,62 % |
| Nektar Therapeutics | 4 | 1 | 1 | 0 | 1,30 € | 2,40 € | 85,04 % |
| Catalent Inc. | 1 | 0 | 0 | 0 | 53,82 € | 55,00 € | 2,19 % |
| Blueprint Medicines Corp | 1 | 0 | 0 | 0 | 106,15 € | - | - |
| Emergent Biosolutions Inc. | 4 | 3 | 1 | 0 | 12,74 € | - | - |
| Novocure Ltd | 1 | 1 | 0 | 0 | 17,34 € | - | - |